logo conference-reports

Conference Reports

При финансовой поддержке logo MSD Oncology

SABCS 2019 – Residual cancer burden after neoadjuvant chemotherapy predicts long-term recurrence

Residual burden accurately predicts long-term event-free survival in a meta-analysis.